Abstract:Background Epidemiological studies report associations of diverse cardiometabolic conditions including obesity with COVID-19 illness, but causality has not been established. We sought to evaluate the associations of 17 cardiometabolic traits with COVID-19 susceptibility and severity using 2-sample Mendelian randomization (MR) analyses. Methods and findings We selected genetic variants associated with each exposure, including body mass index (BMI), at p < 5 × 10 −8 from genome-wide association studies (GWASs). We then calculated inverse-variance-weighted averages of variant-specific estimates using summary statistics for susceptibility and severity from the COVID-19 Host Genetics Initiative GWAS meta-analyses of population-based cohorts and hospital registries comprising individuals with self-reported or genetically inferred European ancestry. Susceptibility was defined as testing positive for COVID-19 and severity was defined as hospitalization with COVID-19 versus population controls (anyone not a case in contributing cohorts). We repeated the analysis for BMI with effect estimates from the UK Biobank and performed pairwise multivariable MR to estimate the direct effects and indirect effects of BMI through obesity-related cardiometabolic diseases. Using p < 0.05/34 tests = 0.0015 to declare statistical significance, we found a nonsignificant association of genetically higher BMI with testing positive for COVID-19 (14,134 COVID-19 cases/1,284,876 controls, p = 0.002; UK Biobank: odds ratio 1.06 [95% CI 1.02, 1.10] per kg/m 2 ; p = 0.004]) and a statistically significant association with higher risk of COVID-19 hospitalization (6,406 hospitalized COVID-19 cases/902,088 controls, p = 4.3 × 10 −5 ; UK Biobank: odds ratio 1.14 [95% CI 1.07, 1.21] per kg/m 2 , p = 2.1 × 10 −5 ). The implied direct effect of BMI was abolished upon conditioning on the effect on type 2 diabetes, coronary artery disease, stroke, and chronic kidney disease. No other cardiometabolic exposures tested were associated with a higher risk of poorer COVID-19 outcomes. Small study samples and weak genetic instruments could have limited the detection of modest associations, and pleiotropy may have biased effect estimates away from the null. Conclusions In this study, we found genetic evidence to support higher BMI as a causal risk factor for COVID-19 susceptibility and severity. These results raise the possibility that obesity could amplify COVID-19 disease burden independently or through its cardiometabolic consequences and suggest that targeting obesity may be a strategy to reduce the risk of severe COVID-19 outcomes.

Systematic review and meta-analyses: What has the application of Mendelian randomization told us about the causal effect of adiposity on health outcomes?

Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis

Obesity is Associated with Increased Severity of Disease in COVID-19 Pneumonia: a Systematic Review and Meta-Analysis

Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis

Unravel the distinct effects of adiposity at different life stages on COVID‐19 susceptibility and severity: A life‐course Mendelian randomization study

Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies

Visceral adipose tissue and risk of COVID-19 susceptibility, hospitalization, and severity: A Mendelian randomization study

Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation

Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies

Evaluating the impact of childhood BMI on the risk of coronavirus disease 2019: A Mendelian randomization study

Genetically Driven Adiposity Traits Increase the Risk of Coronary Artery Disease Independent of Blood Pressure, Dyslipidaemia, Glycaemic Traits

Increased COVID-19 Infection Susceptibility and Adverse Outcomes Due to Obesity: A Systematic Review and Meta-analysis

Assessing Causal Estimates of the Association of Obesity-Related Traits with Coronary Artery Disease Using a Mendelian Randomization Approach

Prioritizing Causal Risk Factors for Severe COVID-19: An Exhaustive Mendelian Randomization Study

Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta-analysis

Human Serum Metabolites as Potential Mediators from Type 2 Diabetes and Obesity to COVID-19 Severity and Susceptibility: Evidence from Mendelian Randomization Study

Extensive Mendelian Randomization Study Identifies Potential Causal Risk Factors for Severe COVID-19

Novel Insights into the Consequences of Obesity: a Phenotype-Wide Mendelian Randomization Study

Observational and genetic associations of adiposity with cardiopulmonary multimorbidity: Linear and nonlinear Mendelian randomization analysis

Adiposity as a cause of cardiovascular disease: a Mendelian randomization study.

Phenome-wide investigation of the causal associations between childhood BMI and adult trait outcomes: a two-sample Mendelian randomization study